Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D

Garry R. Barton (Lead / Corresponding author), Jo Hodgekins, Miranda Mugford, Peter B. Jones, Tim Croudace, David Fowler

    Research output: Contribution to journalArticle

    24 Citations (Scopus)

    Abstract

    The UK National Institute for Health and Clinical Excellence (NICE) has recommended that cost-effectiveness analysis includes the EQ-5D; however, this is often not implemented in the area of mental health.
    Original languageEnglish
    Pages (from-to)170-177
    Number of pages8
    JournalBritish Journal of Psychiatry
    Volume195
    Issue number2
    DOIs
    Publication statusPublished - Aug 2009

    Keywords

    • Psychiatry and Mental health

    Fingerprint Dive into the research topics of 'Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D'. Together they form a unique fingerprint.

  • Cite this